How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example

Research output: Contribution to journalEditorial

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)1485-1487
Number of pages3
JournalOphthalmology
Volume125
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Retinopathy of Prematurity
Standard of Care
Vascular Endothelial Growth Factor A

ASJC Scopus subject areas

  • Ophthalmology

Cite this

@article{9ed55ccdb0b8443b94d8d985efebb87a,
title = "How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example",
author = "Michael Chiang",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.ophtha.2018.04.018",
language = "English (US)",
volume = "125",
pages = "1485--1487",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example

AU - Chiang, Michael

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85053435975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053435975&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2018.04.018

DO - 10.1016/j.ophtha.2018.04.018

M3 - Editorial

AN - SCOPUS:85053435975

VL - 125

SP - 1485

EP - 1487

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 10

ER -